Trials / Completed
CompletedNCT03140514
Urine CXCL10 Chemokine Monitoring Post-renal Transplant
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 241 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study investigators will investigate whether early treatment of allograft rejection, as detected by urine CXCL10-monitoring, improves outcomes in renal allograft recipients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rejection treatment according to clinical standard-of-care | Standard-of-care treatment is based on the severity and phenotype of biopsy-proven rejection |
Timeline
- Start date
- 2017-09-28
- Primary completion
- 2022-07-15
- Completion
- 2022-07-15
- First posted
- 2017-05-04
- Last updated
- 2022-08-11
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03140514. Inclusion in this directory is not an endorsement.